Repligen Corporation Investor Presentation — November 2019

Document content

Repligen Corporation

November 2019 Investor Presentation2

2Safe HarborThis presentation contains forward looking statements which aremade pursuant tothe

safe harbor provisions ofSection 27Aofthe Securities Act of1933 ,asamended, and

Section 21Eofthe Securities Exchange Act of1934 ,asamended .These statements are

subject torisks and uncertainties which may cause ourplans tochange oractual results to

differ materially from those anticipated .Inparticular, unforeseen events outside ofour

control may adversely impact future results .Additional information concerning these

factors isdiscussed inour reports filed with the Securities and Exchange Commission

including recent Form 8-Ks,our most recent Annual Report onForm 10-Kand our most

recent Quarterly report onform 10-Q.The forward looking statements inthis presentation

reflect management’s current views and may become obsolete asaresult ofnew

information, future events orotherwise .We may not update such forward looking

statements toreflect achange ofevents orcircumstances that occur after thedate hereof,

except asrequired bylaw.The industry and market data contained inthis presentation are

based on management’s own estimates, independent publications, government

publications, reports bymarket research firms orother published independent sources,

and, ineach case, arebelieved bymanagement tobereasonable estimates .Although we

believe these sources arereliable, wehave notindependently verified theinformation .3

3Repligen Overview4

SnapshotAn industry leader in

•Addressing needs for efficient, single -

use, flexible manufacturing

•Differentiated products with

increasing brand recognition

•Disruptive technologies at earlier

•Rapidly growing through successful

•Solid base with robust and expanding

global market for biologics

•Multiple manufacturing facilitiesBioprocessing innovator

Preview truncated — download the full document for the complete content.